ClearPoint Neuro (CLPT) Shares Outstanding (Weighted Average) (2011 - 2026)

ClearPoint Neuro's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 6.59% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $29.5 million (up 6.59% YoY), while the FY2025 annual figure was $28.3 million, up 4.76% from the prior year.
• Shares Outstanding (Weighted Average) came in at $29.5 million for Q1 2026 at ClearPoint Neuro, up from $28.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $29.5 million in Q1 2026 to a low of $23.7 million in Q1 2022.
• A 5-year average of $26.1 million and a median of $25.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) grew 25.62% in 2022 and increased 0.41% in 2023, its largest moves.
• ClearPoint Neuro's Shares Outstanding (Weighted Average) stood at $24.2 million in 2022, then advanced by 1.75% to $24.6 million in 2023, then gained by 9.85% to $27.0 million in 2024, then increased by 4.76% to $28.3 million in 2025, then rose by 4.35% to $29.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $29.5 million, $28.3 million, and $28.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison